This revealed that GPx2 KD further enriched cluster 5 in basal/mesenchymal-like genes (KRT14, ITGA6, FGFR1, COLA9A3, S100s) relative to cluster 5 in control tumor (SI Appendix, Fig. S9D). The gene discussed is GPX2; the disease is neoplasm.